News About: Pharm. Industry
Korea Prime to be listed on main bourse in 2011
SK Securities Co. said Korea Prime Pharmaceutical Co. will go public in 2011 until the company meets the requirements for listing.
The company will be listed on the main bourse through the initial public offerings,...
Multinationals have positive views on Korean drug makers
Overall, foreign-invested pharmaceutical firms feel that domestic pharmaceutical firms have performed their business operations well in terms of production facilities, licensing procedures and sales activities, accord...
Plavix generics market steams up
Plavix generics market steams up
The domestic market of Sanofi-Aventis’s Plavix (clopidogrel) generic market has been gaining momentum as smaller manufacturers see opportunities in the field where t...
Park named Janssen China chiefPark Je-wha, former president of Janssen Korea will be appointed CEO of Janssen China as of August 1, this year.
Park, 57, will also become regional CEO covering Taiwan and H...
|
Dong-A signs $168 million export dealDong-A Pharmaceutical signed export contracts for Zydena, the erectile dysfunction treatment, with a total of 16 countries including Brazil and Malaysia worth $168 million
Th...
|
Manufacturers moving to raise OTC products
Handok Pharm is poised to raise its Festal price once again amid the latest inflationary pressures stemming from surging oil prices and rising raw material costs.
Sources say the wholesaler price of Festal has been...
Hyundai to release anti-oxidant therapy in 2014Hyundai Pharm has recently entered into a licensing agreement with Nippon Zoki Pharmaceutical Co. to develop and commercialize a new anti-oxidant (code name: HD003) for treatmen...
|
Boryung, Metholatum clash on topical analgesics & anti-inflammatory agents
With the race for leadership in the next-generation display market between Boryung Pharm and Metholatum Co. getting increasingly fierce, signals of a market division are looming large at competitors.
Boryung has la...
Drug makers urged to nurture promotional professionals
Domestic pharmaceutical firms should focus on nurturing professionals in the promotion sector as the number of these professional has been on the gradual decrease due to pharmaceutical firms’ lack of recognition.
A...
Positive list system to face opposition
The so-called positive system is triggering a backlash from the domestic pharmaceutical industry.
Under the new drug-pricing policy called the “positive list system,” better-priced and more effective medicines will...
